Skip to content
10-K

Annual Report

HOOKIPA PHARMA INC.

0001558370-25-001853

← back to feed
Filed
Feb 28, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2024 · Dec 31, 2024 12.54M sh
Shares Diluted restated FY 2024 · Dec 31, 2023 9.45M sh
Shares Diluted restated FY 2024 · Dec 31, 2022 6.55M sh
Capex FY 2024 · Dec 31, 2024 $194K
Capex FY 2024 · Dec 31, 2023 $4.16M
Capex FY 2024 · Dec 31, 2022 $5.02M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$76.98M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$57.52M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$20M
Cash And Equivalents FY 2024 · Dec 31, 2024 $39.68M
Cash And Equivalents FY 2024 · Dec 31, 2023 $117.1M
Stockholders Equity FY 2024 · Dec 31, 2024 $51.21M
Stockholders Equity FY 2024 · Dec 31, 2023 $89.86M
Stockholders Equity FY 2024 · Dec 31, 2022 $102.52M
Stockholders Equity FY 2024 · Dec 31, 2021 $89.59M
Current Liabilities FY 2024 · Dec 31, 2024 $24.65M
Current Liabilities FY 2024 · Dec 31, 2023 $41.99M
Total Liabilities FY 2024 · Dec 31, 2024 $31.33M
Total Liabilities FY 2024 · Dec 31, 2023 $71.48M
Current Assets FY 2024 · Dec 31, 2024 $80.67M
Current Assets FY 2024 · Dec 31, 2023 $147.12M
Total Assets FY 2024 · Dec 31, 2024 $82.55M
Total Assets FY 2024 · Dec 31, 2023 $161.34M
Eps Diluted FY 2024 · Dec 31, 2024 −$3.47
Eps Diluted restated FY 2024 · Dec 31, 2023 −$8.63
Eps Diluted restated FY 2024 · Dec 31, 2022 −$9.91
Eps Basic FY 2024 · Dec 31, 2024 −$3.47
Eps Basic restated FY 2024 · Dec 31, 2023 −$8.63
Eps Basic restated FY 2024 · Dec 31, 2022 −$9.91
Sga Expense FY 2024 · Dec 31, 2024 $20.23M
Sga Expense FY 2024 · Dec 31, 2023 $18.63M
Sga Expense FY 2024 · Dec 31, 2022 $18.76M
Rd Expense FY 2024 · Dec 31, 2024 $68.51M
Rd Expense FY 2024 · Dec 31, 2023 $86.42M
Rd Expense FY 2024 · Dec 31, 2022 $68.65M
Net Income FY 2024 · Dec 31, 2024 −$43.5M
Net Income FY 2024 · Dec 31, 2023 −$81.58M
Net Income FY 2024 · Dec 31, 2022 −$64.92M
Operating Income FY 2024 · Dec 31, 2024 −$51.46M
Operating Income FY 2024 · Dec 31, 2023 −$97.69M
Operating Income FY 2024 · Dec 31, 2022 −$73.16M
Revenue FY 2024 · Dec 31, 2024 $43.95M
Revenue FY 2024 · Dec 31, 2023 $20.13M
Revenue FY 2024 · Dec 31, 2022 $14.25M